Di Luzio N R, Williams D L, McNamee R B, Edwards B F, Kitahama A
Int J Cancer. 1979 Dec 15;24(6):773-9. doi: 10.1002/ijc.2910240613.
A soluble fraction of particulate glucan was prepared and evaluated for its anti-tumor and anti-bacterial activity. Thin-layer chromatographic analysis indicated that the soluble preparation was composed of a variety of polyglucoses. Intravenous administration of soluble or particulate glucan resulted in significant reductions in the growth of a syngeneic anaplastic mammary carcinoma and melanoma B16. Survival data demonstrated that intravenous administration of soluble or particulate glucan prolonged survival of A/J and C57BL/6J mice with subcutaneous tumor implants. As regards to bacterial infections, soluble and particulate glucan decreased renal necrosis in S. aureus challenged mice as compared to control mice. Although the exact nature of the active soluble fraction(s) of glucan remains to be delineated, these studies demonstrate that a soluble glucan preparation exhibits significant anti-tumor and anti-staphylococcal activity. The active soluble fraction of particulate glucan may be preferable to particulate glucan in view of the inherent ease of parenteral administration.
制备了颗粒状葡聚糖的可溶性部分,并对其抗肿瘤和抗菌活性进行了评估。薄层色谱分析表明,该可溶性制剂由多种聚葡萄糖组成。静脉注射可溶性或颗粒状葡聚糖可显著降低同基因间变性乳腺癌和黑色素瘤B16的生长。生存数据表明,静脉注射可溶性或颗粒状葡聚糖可延长皮下植入肿瘤的A/J和C57BL/6J小鼠的生存期。关于细菌感染,与对照小鼠相比,可溶性和颗粒状葡聚糖可降低金黄色葡萄球菌攻击小鼠的肾坏死。尽管葡聚糖活性可溶性部分的确切性质仍有待阐明,但这些研究表明,一种可溶性葡聚糖制剂具有显著的抗肿瘤和抗葡萄球菌活性。鉴于静脉给药固有的便利性,颗粒状葡聚糖的活性可溶性部分可能比颗粒状葡聚糖更可取。